
SOLVD Health Launches 5-Year Post-Approval Study on AvertD® Genetic Test
SOLVD Health, a patient intelligence company focused on precision solutions to improve health outcomes, has launched a comprehensive post-approval study for AvertD®, the first FDA-approved genetic test to assess the…













